Testicular Cancer & Fertility Preservation
Germ Cell Tumors and Pre-Treatment Sperm Banking
Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Cancer condition; fertility preservation is a procedural standard, not a drug
Reference only. Not medical advice.
This is something to take to a clinician. The Atlas can tell you what is known about testicular cancer & fertility preservation in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Testicular germ cell tumor is the most common solid malignancy in men aged roughly 15-40, accounting for about 1% of male cancers overall but a large share of cancers in young men. Both the disease and its treatments (orchiectomy, chemotherapy, radiation, and retroperitoneal lymph-node dissection) can impair fertility, and many patients already have reduced semen quality at diagnosis. Sperm banking before treatment is the recommended standard of care, yet counseling and uptake remain low in practice.
The most common cancer in young men, and a moment when fertility decisions cannot wait.
What people take it for
What it is taken for. Approval, where it exists, covers only some of these.
How it works
Orchiectomy removes one testis (usually leaving the other), but the remaining testis and overall spermatogenesis may be compromised by the tumor's systemic effects, chemotherapy gonadotoxicity, scatter radiation, or nerve injury from retroperitoneal lymph-node dissection (which can cause anejaculation or retrograde ejaculation). Because some patients are already oligospermic or azoospermic at diagnosis, the practical priority is to bank any available sperm before any treatment begins; when the ejaculate lacks sperm, surgical retrieval (onco-TESE) at the time of orchiectomy can salvage sperm from the removed or contralateral testis.
The counseling gap
Although guidelines such as the EAU strongly recommend discussing sperm banking with every man before testicular cancer treatment, real-world data show a substantial fraction never receive counseling and far fewer actually bank. The window is narrow: treatment is often urgent, and post-treatment semen quality can take years to recover or may never normalize. Ēnel emphasizes that the highest-value action happens before the first dose of chemotherapy or the surgical date.
Safety in detail
This involves cancer treatment with significant physiological effects requiring evaluation and monitoring by qualified oncology and urology specialists. Fertility-preservation decisions are time-sensitive and should be made with the care team before treatment begins.
What it does to fertility
Treatment is the dominant fertility threat: chemotherapy (especially alkylating-agent or platinum-based regimens) and radiation can cause prolonged or permanent azoospermia, and RPLND can disrupt ejaculation. Testosterone may also fall after bilateral or compromised testicular function, occasionally requiring replacement, which itself further suppresses any remaining spermatogenesis and underscores banking first.
What people get wrong
Often saidLosing one testicle means infertility
ActuallyThe remaining testis usually maintains hormone and sperm production; many survivors father children naturally.
Often saidYou can always bank sperm after treatment
ActuallyChemotherapy and radiation are gonadotoxic; banking should occur before treatment, ideally before orchiectomy.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
How we got here
Testicular cancer was once frequently fatal, but cisplatin-based chemotherapy introduced in the 1970s made it one of the most curable solid tumors, dramatically increasing the population of young survivors for whom fertility matters. This survivorship success drove the development of oncofertility as a discipline and the integration of pre-treatment sperm banking into guidelines.
- 1970sCisplatin chemotherapy transforms testicular cancer into a highly curable disease
- 2000s-presentPre-treatment sperm banking embedded in guidelines; oncofertility formalized
At a glance
- Peak age
- ~15-40 years
- Share of cancers in young men
- Leading solid tumor
- Pre-treatment recommendation
- Sperm banking (EAU strong)
- Counseling gap
- Often well under 50% counseled
- When ejaculate has no sperm
- Onco-TESE at orchiectomy
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Testicular Cancer & Fertility Preservation. A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- What can go wrong. We have not written the risk line for this one. Read the safety section below rather than treating its absence as reassurance.
- Where we land. We have not taken a position on this yet.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
EAU Guidelines on Sexual and Reproductive Healthcurrent
Strong recommendation to offer and discuss sperm cryopreservation with all men prior to testicular cancer treatment
Survivorship and fertility-counseling auditsvarious
Documented low rates of timely fertility counseling and sperm banking among testicular cancer patients